You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Dusseldorf (1)

Condition

Acute HIT II (Heparin-induced Thrombocytopenia Type II) (1)

Heparin Induced Thrombocytopenia (HIT) (1)

Thrombosis (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 4 (1)

Sponsor

GlaxoSmithKline (1)

Heinrich-Heine University, Duesseldorf (1)

National Institutes of Health Clinical Center (CC) (1)

Collaborator

Intervention

lepirudin (3)

argatroban (2)

danaparoid (1)

fondaparinux (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (2)

Observational (1)

lepirudin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Patients With Acute Heparin-induced Thrombocytopenia Type II

Completed

Has Results

Acute HIT II (Heparin-induced Thrombocytopenia Type II)

lepirudin
+3 more

(no location specified)

Jun 6, 2017

Heparin Induced Thrombocytopenia (HIT) Trial in Düsseldorf (Argatroban, Lepirudin)

Terminated

Heparin Induced Thrombocytopenia (HIT)

Argatroban
Lepirudin

Düsseldorf, Germany

Universitätsklinikum Düsseldorf Klinik für Anästhesiologie

Jun 20, 2012

Thrombosis Trial run by the CC (Lepirudin)

Completed

Thrombosis

Lepirudin

Bethesda, Maryland

National Institutes of Health Clinical Center (CC)

Mar 3, 2008